期刊文献+

复发性肝癌大分割适形放疗的疗效及预后分析 被引量:5

Therapeutic effect of hypofractionated three-dimensional conformal radiotherapy on recurrent hepatocellular carcinoma and the prognostic analysis
暂未订购
导出
摘要 目的:探讨大分割三维适形放射治疗(3-dimensional conformal radiation therapy,3DCRT)对复发性肝癌的疗效及其预后的影响因素。方法:对46例不能手术切除的复发性肝癌进行大分割3DCRT,根据肿瘤体积大小,每次分割剂量4~8Gy,每周3次,隔日1次,照射次数为6~15次(中位10次),总治疗时间为2~5周(中位治疗时间4周),相当于生物效应剂量(biological effective dose,BED)56~94Gy,中位剂量79Gy。观察近期疗效,用Kaplan-Meier方法进行生存分析,用COX比例风险模型分析多因素对生存率的影响。结果:肿瘤完全缓解(complete remission,CR)率为10.9%,部分缓解(partial remis-sion,PR)率为56.5%,病情无变化(nochange,NC)率为21.7%,进展(progressive disease,PD)率为10.9%,总有效率(CR+PR)为67.4%。1、2和3年的累积生存率分别为60.3%、43.4%和27.4%,中位生存时间为18个月(2~85个月)。单因素分析显示大体肿瘤体积(gross tumor volume,GTV)、病灶个数、肝硬化和复发方式对预后的影响均有统计学意义(P<0.05),而多因素分析显示病灶个数、复发方式和GTV大小对生存率的影响有统计学意义(P<0.05)。放射性肝炎和胃肠管出血是最常见的并发症。结论:大分割3DCRT对复发性肝癌患者有较好的疗效,其放疗不良反应可接受。病灶个数、复发方式和肿瘤的大小是患者的独立预后因素。 Objective:To investigate the therapeutic effect of hypofractionated three-dimensional conformal radiotherapy (3DCRT) on recurrent hepatocellular carcinoma (HCC) and elucidate the prognostic factors. Methods:Forty-six patients with unresec-table recurrent HCC were treated with hypofractionated 3DCRT. According to the volume of the tumors,the fractionated dosage was set at 4-8 Gy/time,3 times/week,1 time every other day,6-15 times (median 10 times). The total therapy time was 2-5 weeks (median 4 weeks),and the biological effective dose (BED) was 56-94 Gy (median BED 79 Gy). The short-term effects were observed and the survival rates were analyzed using the Kaplan-Meier method. The Cox proportional hazard model was used to analyze the effect of multiple factors on survival rate. Results:The complete remission (CR) rate was10.9%,and partial remission rate (PR) was 56.5%. The no change (NC) ratio was 21.7%,and the progressive disease (PD) ratio was 10.9%. The response rate (CR+ PR) was 67.4%. The 1-,2-,3-year overall survival rates were 60.3%,43.4%,and 27.4%,respectively. The median survival time was 18 months (from 2 months to 85 months). Univariate conditional logistic regression model indicated that gross tumor volume (GTV) ,the number of lesions,hepato-cirrhosis and recurrence pattern were associated with prognosis. Multivariate analysis showed that the number of lesions,recurrence pattern and the size of GTV were independent prognostic factors (P〈0.05). Radiation-induced liver disease (RILD) and gastrointestinal bleeding were the most common treatment-related complications. Conclusion:Hypofractionated 3DCRT is effective in the treatment of unresectable recurrent HCC and the adverse reactions are tolerable. The number of lesions,category of recurrence and the size of GTV are identified as the independent factors for predicting the prognosis of recurrent HCC.
出处 《肿瘤》 CAS CSCD 北大核心 2009年第10期980-984,共5页 Tumor
基金 广西省自然科学基金资助项目(编号:0728198)
关键词 肝细胞 复发 放射疗法 适形 预后 Carcinoma hepatocellular Recurrence Radiotherapy conformal Prognosis
  • 相关文献

参考文献11

二级参考文献30

  • 1刘永锋,李桂臣.要合理应用和正确评价肝癌的非手术治疗方法[J].中国实用外科杂志,2004,24(8):449-450. 被引量:22
  • 2蒋国梁.原发性肝癌治疗的新方法——三维适形放疗[J].癌症进展,2006,4(4):279-283. 被引量:39
  • 3杨秉辉 见:中国抗癌协会 编.原发性肝癌[A].见:中国抗癌协会,编.新编常见恶性肿瘤诊治规范[C].北京:中国协和医科大学出版社,1999.389-479.
  • 4Robertson JM, Lawrence TS, Andrews JC, et al. Long-term results of hepatic after fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers. Int J Radiat Oncol Biol Phys,1997,37:325-330.
  • 5张旭光 张临泉 朱迎广 主编.肝癌[A].朱迎广,主编.放射肿瘤学[C].北京: 科学技术文献出版社,2001.354-362.
  • 6Tobe T,Kameda H,Ohto M,et al.Parimary liver cancer in Japan MJ[M].Tokyo:springer lag,1992.235-242.
  • 7Zeng ZC,Tang ZY,Wu ZQ,et al.Phase I clinical trial of oral Furtulon and combined hepatic arterial chemoembolization and radiotherapy in unresectable primary liver cancers,including clinicopathologic study[J].Am J Clin Oncol (CCT),2000,23(5):449-454.
  • 8Zeng ZC,Tang ZY,Yang BH,et al.Comparison between radio immunotherapy and external beam radiation therapy for patients with hepatocellular carcinoma[J].Eur J Nucl Med,2002,29(12):1657-1663.
  • 9Park W,Lira do H,Paik SW,et al.Local radiotherapy for patients with unresectable hepatocellular carcinoma[J].Int J Radiat Oncol Biol Phys,2005,61(4):1143-1149.
  • 10Choi BO,Jang HS,Kang KM,et al.Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma[J].JPN J Clin Oncol,2006,36(3):154-158.

共引文献245

同被引文献39

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部